<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01179152</url>
  </required_header>
  <id_info>
    <org_study_id>hermanasthma</org_study_id>
    <nct_id>NCT01179152</nct_id>
  </id_info>
  <brief_title>Study of Preventive Treatment With Symbicort or Budicort Turbohaler in Childhood Asthma Return to School Epidemic</brief_title>
  <official_title>Childhood Asthma and Return to School: the September Epidemic Exacerbation in Israel.A Controlled Trial of the Effectiveness of Preventive Treatment With Symbicort or Budicort Turbuhaler</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      During the second week of September( week 38 of the year)there are recorded data of
      exacerbation of asthma all over the world, including Israel. A short preventive treatment of
      6 weeks may reduce asthma exacerbation in children,reduce primary care and ER visiting and
      hospitalization.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During the second week of September( week 38 of the year)there are recorded data of
      exacerbation of asthma all over the world, including Israel. A short preventive treatment of
      6 weeks may reduce asthma exacerbation in children,reduce primary care and ER visiting and
      hospitalization.

      We will study the effectiveness of Budicort or Symbicort turbuhaler as a preventive treatment
      in children aged 6-18 years.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2010</start_date>
  <completion_date type="Anticipated">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>reduction of asthma exacerbation during the study period</measure>
    <time_frame>An average time of 8 weeks</time_frame>
    <description>less asthma exacerbation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>less primary care physician visits</measure>
    <time_frame>An average time of 8 weeks</time_frame>
    <description>less primary care physician visits less ER visits less hospitalization due to asthma exacerbation</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">225</enrollment>
  <condition>Asthma Exacerbation</condition>
  <arm_group>
    <arm_group_label>Budicort</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>75 children will receive treatment with Budicort 200 mcg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Symbicort</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>75 children will receive treatment with Symbicort 160 mcg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>counselling</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>75 children who will not treated as their request but will be folowedup</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Budesonide turbuhaler, Budesonide+Formoterol turbuhaler</intervention_name>
    <description>Budesonide 200 mcg turbuhaler or Budesonide+Formoterol 160mcg turbuhaler</description>
    <arm_group_label>Budicort</arm_group_label>
    <arm_group_label>Symbicort</arm_group_label>
    <arm_group_label>counselling</arm_group_label>
    <other_name>Budesonide turbuhaler</other_name>
    <other_name>Budesonide+Formoterol turbuhaler</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        age : 6-18 years suffering from asthma asthma exacerbation during 1/9/2009-15/10/2009

        Exclusion Criteria:

        any chronic condition that can involve respiratory tract (other than asthma) treated as
        prevention with ICS or montelukast from July 2010 Treated with oral steroids during the
        August 2010 asthma exacerbation one week prior study inclusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Avner He Cohen, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clalit Health Services</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Avner He Cohen, MD</last_name>
    <phone>972-3-9398200</phone>
    <email>hermanc@post.tau.ac.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Meir Medical Center</name>
      <address>
        <city>Kfar Saba</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Avner He Cohen, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Johnston NJ, Johnston SL, Duncan JM, Greene JM,Keith PK,Roy M, Wsaerman S, Sears MR. The september epidemic of asthma exacerbation in children:a search for etiology. J allergy Clin Immunol 2005,115;132-8 Scheuerman O, Meyerowitch J, Marcus N, Hoffer V, Batt E , Garty B-Z. The september epidemic of asthma in Israel. J of Asthma 2009;46;652-5 Johnston NW, Mandhane PJ, Dai J, Duncan JM, Greene JM,Lambert K, Sears Mr. Attenuation of the september epidemic of asthma exacerbation in children: A randomized controlled trial of montelukast added to usual therapy. Pediatrics;120;e702-e712.</citation>
  </reference>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 9, 2010</study_first_submitted>
  <study_first_submitted_qc>August 10, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2010</study_first_posted>
  <last_update_submitted>March 16, 2012</last_update_submitted>
  <last_update_submitted_qc>March 16, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 19, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>asthma, september epidemic, children, preventive</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Formoterol Fumarate</mesh_term>
    <mesh_term>Budesonide</mesh_term>
    <mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

